Aeon Global Health Corp. (AGHC) Financial Statements (2024 and earlier)

Company Profile

Business Address 2225 CENTENNIAL DRIVE
GAINESVILLE, 30504
State of Incorp. DE
Fiscal Year End June 30
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7231,1221,4152471,2943,715
Cash and cash equivalents7231,1221,4152471,0843,505
Short-term investments     210210
Restricted cash and investments  121121256256 
Receivables2,5071,0212,143274508566
Inventory, net of allowances, customer advances and progress billings4533483386032,9373,959
Inventory4533483386032,9373,959
Other undisclosed current assets5459171222259944
Total current assets:3,7382,6704,1871,6025,2549,184
Noncurrent Assets
Property, plant and equipment1,4212,2043,477301448733
Intangible assets, net (including goodwill)   5,5074,0684,1212,360
Goodwill   3,318505050
Intangible assets, net (excluding goodwill)   2,1894,0184,0712,310
Deposits noncurrent assets  1010   
Other noncurrent assets    3565931,194
Deferred tax assets, net 5,81611,84838,493   
Other undisclosed noncurrent assets    (2,164)(2,188)(278)
Total noncurrent assets:7,23714,06247,4872,5612,9744,009
TOTAL ASSETS:10,97516,73251,6734,1638,22813,193
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5,1754,9916,4822,1092,8063,459
Interest and dividends payable985645    
Taxes payable516     
Accounts payable1,4372,1784,3291,410  
Accounts payable and other accrued liabilities 3,324
Accrued liabilities2,2382,1682,153569  
Other undisclosed accounts payable and accrued liabilities    1302,806135
Debt 3,050 2,9782,150 724
Deferred rent credit195
Derivative instruments and hedges, liabilities1,324551    
Deferred revenue and credits 142 6778150
Due to related parties 2,545    
Other undisclosed current liabilities6084282,158214  
Total current liabilities:10,3528,65611,6184,5402,8844,333
Noncurrent Liabilities
Liabilities, other than long-term debt1354511488126184
Deferred revenue and credits 4511488126184
Deferred rent credit135
Due to related parties      
Total noncurrent liabilities:1354511488126184
Total liabilities:10,4878,70111,7324,6283,0104,517
Equity
Equity, attributable to parent4898,03039,941(465)5,2188,676
Preferred stock636363696969
Common stock2696423935
Additional paid in capital45,08944,30738,316205,909201,492197,409
Retained earnings (accumulated deficit)(44,689)(36,349)1,556(206,485)(196,382)(188,837)
Total equity:4898,03039,941(465)5,2188,676
TOTAL LIABILITIES AND EQUITY:10,97516,73251,6734,1638,22813,193

Income Statement (P&L) ($ in thousands)

6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Revenues16,30120,19934,5773,6895,5564,827
Revenue, net 20,19934,5773,6895,5564,827
Cost of revenue(3,802)(4,200)(6,877)(1,877)(3,759)(3,454)
Gross profit:12,49915,99827,7001,8121,7971,373
Operating expenses(12,498)(15,956) (10,707)(12,673)(12,198)
Other undisclosed operating income (loss)(782)(5,422)(21,903)1893,7593,454
Operating income (loss):(781)(5,379)5,797(8,706)(7,117)(7,371)
Nonoperating income (expense)(1,123)(46)(207)(994)(26)(3,978)
Investment income, nonoperating(773)828    
Other nonoperating expense(210)(160)  (26)(3,978)
Interest and debt expense (42)(258)(115)(592)(1)(1,060)
Income (loss) from continuing operations before equity method investments, income taxes:(1,945)(5,684)5,475(10,292)(7,144)(12,409)
Other undisclosed income from continuing operations before income taxes 42258115   
Income (loss) from continuing operations before income taxes:(1,903)(5,426)5,590(10,292)(7,144)(12,409)
Income tax expense(6,097)(26,648)(325)   
Income (loss) from continuing operations:(8,000)(32,074)5,265(10,292)(7,144)(12,409)
Income (loss) before gain (loss) on sale of properties:(8,000)(32,074)5,265(10,292)(7,144)(12,409)
Net income (loss):(8,000)(32,074)5,265(10,292)(7,144)(12,409)
Other undisclosed net income attributable to parent    59211,060
Net income (loss) attributable to parent:(8,000)(32,074)5,265(9,700)(7,143)(11,349)
Preferred stock dividends and other adjustments(340)(359)(160)   
Other undisclosed net loss available to common stockholders, basic    (403)(2,419) 
Net income (loss) available to common stockholders, basic:(8,340)(32,432)5,105(10,103)(9,562)(11,349)
Interest on convertible debt   46   
Convertible preferred dividends   160   
Net income (loss) available to common stockholders, diluted:(8,340)(32,432)5,311(10,103)(9,562)(11,349)

Comprehensive Income ($ in thousands)

6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Net income (loss):(8,000)(32,074)5,265(10,292)(7,144)(12,409)
Comprehensive income (loss):(8,000)(32,074)5,265(10,292)(7,144)(12,409)
Other undisclosed comprehensive income, net of tax, attributable to parent    59211,060
Comprehensive income (loss), net of tax, attributable to parent:(8,000)(32,074)5,265(9,700)(7,143)(11,349)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: